BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 26560086)

  • 1. Central delivery of iodine-125-labeled cetuximab, etanercept and anakinra after perispinal injection in rats: possible implications for treating Alzheimer's disease.
    Roerink ME; Groen RJ; Franssen G; Lemmers-van de Weem B; Boerman OC; van der Meer JW
    Alzheimers Res Ther; 2015 Nov; 7(1):70. PubMed ID: 26560086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid improvement in verbal fluency and aphasia following perispinal etanercept in Alzheimer's disease.
    Tobinick EL; Gross H
    BMC Neurol; 2008 Jul; 8():27. PubMed ID: 18644112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perispinal etanercept: potential as an Alzheimer therapeutic.
    Griffin WS
    J Neuroinflammation; 2008 Jan; 5():3. PubMed ID: 18186919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perispinal etanercept for treatment of Alzheimer's disease.
    Tobinick E
    Curr Alzheimer Res; 2007 Dec; 4(5):550-2. PubMed ID: 18220520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid cognitive improvement in Alzheimer's disease following perispinal etanercept administration.
    Tobinick EL; Gross H
    J Neuroinflammation; 2008 Jan; 5():2. PubMed ID: 18184433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perispinal Delivery of CNS Drugs.
    Tobinick EL
    CNS Drugs; 2016 Jun; 30(6):469-80. PubMed ID: 27120182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of post-anesthesia dementia with perispinal etanercept injection and hyperbaric oxygen therapy: a case report.
    Best S; Pavel DG
    J Med Case Rep; 2017 Apr; 11(1):105. PubMed ID: 28407792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deciphering the physiology underlying the rapid clinical effects of perispinal etanercept in Alzheimer's disease.
    Tobinick E
    Curr Alzheimer Res; 2012 Jan; 9(1):99-109. PubMed ID: 22191562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perispinal etanercept: a new therapeutic paradigm in neurology.
    Tobinick E
    Expert Rev Neurother; 2010 Jun; 10(6):985-1002. PubMed ID: 20518613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid improvement of chronic stroke deficits after perispinal etanercept: three consecutive cases.
    Tobinick E
    CNS Drugs; 2011 Feb; 25(2):145-55. PubMed ID: 21254790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid improvement in severe long COVID following perispinal etanercept.
    Tobinick E; Spengler RN; Ignatowski TA; Wassel M; Laborde S
    Curr Med Res Opin; 2022 Dec; 38(12):2013-2020. PubMed ID: 35791687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perispinal etanercept for neuroinflammatory disorders.
    Tobinick E
    Drug Discov Today; 2009 Feb; 14(3-4):168-77. PubMed ID: 19027875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perispinal etanercept produces rapid improvement in primary progressive aphasia: identification of a novel, rapidly reversible TNF-mediated pathophysiologic mechanism.
    Tobinick E
    Medscape J Med; 2008 Jun; 10(6):135. PubMed ID: 18679537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized controlled trial validating the use of perispinal etanercept to reduce post-stroke disability has wide-ranging implications.
    Clark IA
    Expert Rev Neurother; 2020 Mar; 20(3):203-205. PubMed ID: 32028804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of etanercept delivered by perispinal administration for chronic back and/or neck disc-related pain: a study of clinical observations in 143 patients.
    Tobinick E; Davoodifar S
    Curr Med Res Opin; 2004 Jul; 20(7):1075-85. PubMed ID: 15265252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase I/II parallel double-blind randomized controlled clinical trial of perispinal etanercept for chronic stroke: improved mobility and pain alleviation.
    Ralph SJ; Weissenberger A; Bonev V; King LD; Bonham MD; Ferguson S; Smith AD; Goodman-Jones AA; Espinet AJ
    Expert Opin Investig Drugs; 2020 Mar; 29(3):311-326. PubMed ID: 31899977
    [No Abstract]   [Full Text] [Related]  

  • 17. Rapid intracerebroventricular delivery of Cu-DOTA-etanercept after peripheral administration demonstrated by PET imaging.
    Tobinick EL; Chen K; Chen X
    BMC Res Notes; 2009 Feb; 2():28. PubMed ID: 19284700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The biologics anakinra and etanercept prevent cytokine-induced growth retardation in cultured fetal rat metatarsal bones.
    Fernandez-Vojvodich P; Karimian E; Sävendahl L
    Horm Res Paediatr; 2011; 76(4):278-85. PubMed ID: 21952292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and biological evaluation of novel radioiodinated imidazopyridine derivatives for amyloid-β imaging in Alzheimer's disease.
    Chen CJ; Bando K; Ashino H; Taguchi K; Shiraishi H; Fujimoto O; Kitamura C; Matsushima S; Fujinaga M; Zhang MR; Kasahara H; Minamizawa T; Jiang C; Ono M; Higuchi M; Suhara T; Yamada K; Ji B
    Bioorg Med Chem; 2014 Aug; 22(15):4189-97. PubMed ID: 24931274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumour necrosis factor modulation for treatment of Alzheimer's disease: rationale and current evidence.
    Tobinick E
    CNS Drugs; 2009 Sep; 23(9):713-25. PubMed ID: 19689163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.